Non-muscle Invasive Bladder Cancer Clinical Trials in Tampa, Florida

5 studies are recruiting for non-muscle invasive bladder cancer in Tampa, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

    The purpose of this research is to determine whether bladder cancer monitoring can be improved by replacing some cystoscopy procedures with urine testing. Specifically, this study examines whether there are any differences in urinary symptoms, discomfort, number of invasive procedures, anxiety, com…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    James A. Haley Veterans' Hospital, Tampa, Florida
    Locations
    10 in total
    Run by
    White River Junction Veterans Affairs Medical Center
  2. A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

    This is a phase 2 open-label two cohort study of durvalumab plus monalizumab in patients with BCG-unresponsive or BCG-exposed CIS NMIBC. Arm A will enroll 43 participants who have cancer in situ (CIS) with or without high grade papillary urothelial cancer. Arm B will enroll 17 participants who do n…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Moffitt Cancer Center, Tampa, Florida
    Locations
    5 in total
    Run by
    John Sfakianos
  3. A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

    The purpose of this study is to learn how a new medicine called PF-08052667 works when used by itself or together with another medicine called Bacillus Calmette Guerin (BCG), and/or a medicine called sasanlimab. This study is for adults who have a type of bladder cancer that hasn't spread into the …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Moffitt Cancer Center - International Plaza, Tampa, Florida
    Locations
    68 in total
    Run by
    Pfizer
  4. Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

    Blue light cystoscopy (BLC) is a diagnostic procedure in bladder cancer where the inside of the bladder is observed with a camera to detect bladder lesions. Unlike regular white light cystoscopy, blue light cystoscopy makes use of a drug that induces fluorescence under blue light preferentially in …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Moffitt Cancer Center, Tampa, Florida
    Locations
    8 in total
    Run by
    Photocure
  5. A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

    The goal of the study is to learn about the safety of Sacituzumab Tirumotecan and if people can tolerate it when given in the bladder and find the highest dose that people can take without having certain problems. Researchers will then choose a dose level of Sacituzumab Tirumotecan to use in future…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Moffitt Cancer Center ( Site 0057), Tampa, Florida
    Locations
    13 in total
    Run by
    Merck Sharp & Dohme LLC

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.